Dr. Eric Wayne Dean, MD

Dr. Dean practices at EvergreenHealth Medical Center Kirkland in Kirkland, Washington.

Dr. Dean's NPI, 1366632671, was assigned on August 1, 2007. Dr. Dean graduated from Harvard Medical School in 2005. Dr. Dean holds Washington license MD60602069.

Dr. Dean's primary practice is EvergreenHealth Medical Center Kirkland, at 12040 Ne 128th St, Kirkland, WA 98034 in King County. The practice phone is (425) 899-1000.

Dr. Dean's primary practice is EvergreenHealth Medical Center Kirkland in Kirkland, Washington. Dr. Dean is also affiliated with EvergreenHealth Medical Center. The medical group on file is UW Physicians. Dmand AI also links Dr. Dean to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dean practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Dean's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Dean is licensed in Washington.

CMS data shows 920 Medicare services from Dr. Dean across 6 procedure codes in 2024, for 214 Medicare patients. Medicare paid $55,328 for them.

CMS counts 214 Medicare patients who saw Dr. Dean in 2024. The largest group is 75 to 84, with 97 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dean's median patient age at 71, with 42% women.

In 2024, Dr. Dean wrote 906 Medicare Part D claims for 129 patients. 88% of them were for generic drugs. CMS names the drug for 769 of them, across 21 drugs with 11 or more claims each, at $909,717 in total drug cost. In 2023, CMS named 604 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Dean for performance year 2024, reported through an alternative payment model (APM). Dr. Dean accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dean as offering telehealth.

Dmand AI links 2 papers to Dr. Dean in 2015. 2015 was the busiest year, with 2. Dr. Dean has published most often in Nat Commun. Dr. Dean's most frequent co-authors are Djordje Atanackovic, MD, Jennifer Lee Caswell-Jin, MD and Martha Jane Glenn, MD.

Dmand AI links Dr. Dean to 4 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Lymphoma, Non-Hodgkin and Ureteral Neoplasms. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 32 general payments to Dr. Dean from 9 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 79% of the total. Bristol-Myers Squibb Company paid the most, $19,533.

Dr. Dean graduated from Harvard Medical School in 2005.